Patient Blood Management Market

Request for customization Inquire Before Buying

Patient Blood Management Market By Product (Instruments, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic & Testing Instruments), Component (Whole Blood & Red Blood Cells, Blood Components), and End User (Hospitals, Blood Banks) - Forecast Year 2024 – 2031

Healthcare // Medical Devices

Number of Pages: 257 Report Format: pdf Report ID: ZBA-4 Publishing Date: - February, 2022

Frequently Ask Question

Growing awareness regarding the safety of donated blood is the growth opportunities related to the adoption of patient blood management solutions across the globe in the future.

The instruments segment accounted for the highest market share during the forecast period owing to factors such as the increasing number of blood donations and blood donors and technological advancements in blood management instruments.

The global patient blood management market is forecasted to grow at a rate of 7.6% to USD 22.3 Billion in 2029.

The key market players across the globe in the market include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor, Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA